- KCNH2 variants in a family with epilepsy and Long QT syndrome: a case report and literature review
- Mechanical QT and JT intervals by M-mode echocardiography: An extrapolation from the concurrent electrocardiographic tracings
- Bilateral Cardiac Sympathetic Denervation in Patients with Congenital Long QT Syndrome
- Contribution of cytokine-mediated prolongation of QTc interval to the multi-hit theory of Torsade de Pointes
- Assessment of time irreversibility in a time series using visibility graphs
- Long-QT mutations in KCNE1 modulate the 17β-estradiol response of Kv7.1/KCNE1
- Macro T-wave Alternans in Jervell and Lange-Nielsen Syndrome
- The utility of zebrafish cardiac arrhythmia model to predict the pathogenicity of KCNQ1 variants
- Injectable Contraceptive, Depo-Provera, Produces Erratic Beating Patterns in Patient-Specific Induced Pluripotent Stem Cell-derived Cardiomyocytes with Type 2 Long QT Syndrome
- SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19
- A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole
- Novel Calmodulin Variant p.E46K Associated With Severe Catecholaminergic Polymorphic Ventricular Tachycardia Produces Robust Arrhythmogenicity in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- Non-missense variants of KCNH2 show better outcomes in type 2 long QT syndrome
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- Implantable cardioverter-defibrillator in patients with inherited arrhythmia syndromes: A systematic review
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- A need for exhaustive and standardized characterization of ion channels activity. The case of KV11.1
- From gene-specific to function-specific risk stratification in long QT syndrome Type 2: implications for clinical management
- Pediatric Epicardial Devices: Early and Midterm Outcomes
- Combined mexiletine and flecainide for severe long QT syndrome type 3
- Caveolin-3 and Caveolae regulate ventricular repolarization
- 4q25 Microdeletion with Axenfeld-Rieger Syndrome and Developmental Delay
- General anesthesia using propofol infusion for implantation of an implantable cardioverter defibrillator in a pediatric patient with Andersen-Tawil syndrome: a case report
- The TANGO2 disease and the therapeutic challenge of acute arrhythmia management: a case report
- NaV1.6 dysregulation within myocardial T-tubules by D96V calmodulin enhances proarrhythmic sodium and calcium mishandling
- Variant-Specific Therapy for Long QT Syndrome Type-3
- Variant-specific therapy for long QT syndrome type 3
- A QTc risk score in patients with obstructive sleep apnea
- Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation